Yu MC - Search Results

1

Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.

Eriksson AGZ, Graul A, Yu MC, Halko A, Chi DS, Zivanovic O, Gardner GJ, Sonoda Y, Barakat RR, Abu-Rustum NR, Leitao MM Jr. Eriksson AGZ, et al. Among authors: yu mc. Gynecol Oncol. 2017 Aug;146(2):263-267. doi: 10.1016/j.ygyno.2017.05.022. Epub 2017 May 17. Gynecol Oncol. 2017. PMID: 28527673

2

Meta-Analysis on the Efficacy and Safety of Laparoscopic Surgery for Large Gastric Gastrointestinal Stromal Tumors.

Yu M, Wang DC, Wei J, Lei YH, Fu ZJ, Yang YH. Yu M, et al. Am Surg. 2021 Mar;87(3):450-457. doi: 10.1177/0003134820951482. Epub 2020 Oct 7. Am Surg. 2021. PMID: 33026232

3

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy.

Liu S, Zeng S, Xia L, Yu M, Zhang X, Yang H, Ji J, Dong H, Zhang J, Zhang P. Liu S, et al. Breast Cancer Res Treat. 2021 Feb;185(3):629-638. doi: 10.1007/s10549-020-06015-4. Epub 2020 Nov 9. Breast Cancer Res Treat. 2021. PMID: 33165709

4

Primary Closure Following Laparoscopic Common Bile Duct Exploration Combined with Intraoperative Choledochoscopy and D-J Tube Drainage for Treating Choledocholithiasis.

Yu M, Xue H, Shen Q, Zhang X, Li K, Jia M, Jia J, Xu J. Yu M, et al. Med Sci Monit. 2017 Sep 19;23:4500-4505. doi: 10.12659/msm.903753. Med Sci Monit. 2017. PMID: 28924137 Free PMC article.

5

Appleby operation for carcinoma of the body and tail of the pancreas.

Shen Q, Jiang QF, Tian YW, Yu M, Jia JK, Xue HZ. Shen Q, et al. J Cancer Res Ther. 2018 Dec;14(Supplement):S1019-S1023. doi: 10.4103/0973-1482.199383. J Cancer Res Ther. 2018. PMID: 30539839 Free article. Clinical Trial.

6

Surgical operation and re-operation for hepatocellular carcinoma with bile duct thrombosis.

Wang YD, Xue HZ, Jiang QF, Shen Q, Wang LC, Zhang X, Lu B, Yu M, Li K. Wang YD, et al. Chin Med J (Engl). 2010 Aug;123(16):2163-70. Chin Med J (Engl). 2010. PMID: 20819658

7

miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.

Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y. Yu M, et al. Int J Oncol. 2017 Mar;50(3):975-983. doi: 10.3892/ijo.2017.3852. Epub 2017 Jan 17. Int J Oncol. 2017. PMID: 28098858

8

Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses.

Yu M, Wang DC, Li S, Huang LY, Wei J. Yu M, et al. Int J Colorectal Dis. 2022 Apr;37(4):855-868. doi: 10.1007/s00384-022-04122-w. Epub 2022 Mar 12. Int J Colorectal Dis. 2022. PMID: 35279746

9

[Clinical features and prognosis analysis of different breast cancer molecular subtypes].

Yang Q, Chen J, Li HJ, Yu M, Tian CX, Lü Q. Yang Q, et al. Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):42-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575463 Chinese.

10

Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.

Wang YD, Xue HZ, Zhang X, Xu ZQ, Jiang QF, Shen Q, Yu M, Li K, Jia M. Wang YD, et al. Chin Med J (Engl). 2013;126(19):3632-8. Chin Med J (Engl). 2013. PMID: 24112155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page